U.S. Oil and Gas Stock News

Interest in Automatic Data Processing (ADP) has picked up after its private payroll report showed softer job creation than economists expected, while the company delivered solid quarterly earnings and introduced new AI-powered ADP Assist agents. See our latest analysis for Automatic Data Processing. Despite solid earnings and the launch of ADP Assist, the share price has come under pressure, with a 30 day share price return of 10.39% and a year to date share price return of 7.47%, while the 1...

In recent months, Navitas Semiconductor has been shifting away from its mobile and consumer operations toward higher-margin AI infrastructure and industrial electrification applications, even as this transition has weighed on near-term revenue. An important angle for investors is how Navitas’ partnerships, including with Nvidia and major EV and PC makers, could reshape its role across AI and data center supply chains. Next, we’ll examine how this renewed focus on AI infrastructure and...

Why General Dynamics is on investors’ radar today General Dynamics (GD) is drawing fresh attention after recent share price moves, with the stock showing mixed short term performance, including a small 1 day decline and a modest gain over the past week. See our latest analysis for General Dynamics. That small daily share price dip sits against a steadier picture, with General Dynamics posting a 2.5% year to date share price return and a 40.4% 1 year total shareholder return. This suggests...

Parsons (PSN) is back in focus for investors after recent share price moves, with the stock closing at $67.52 and mixed returns across the past week, month, and past 3 months attracting closer attention. See our latest analysis for Parsons. Recent trading has cooled after a strong start to the year, with a 1 day share price return of 1.44% and a 7 day share price return of 4.77% offset by a 21.42% 3 month share price decline. The 1 year total shareholder return of 12.92% contrasts with solid...

Embecta's Q1 2026 Earnings Snapshot Embecta (EMBC) opened its fiscal 2026 with Q1 revenue of US$261.2 million, basic EPS of US$0.75 and net income of US$44.1 million, providing a clear view of how its core diabetes-care franchise is tracking. The company reported quarterly revenue of US$261.9 million in Q1 2025 compared with US$261.2 million in Q1 2026, while basic EPS moved from US$0.25 in Q4 2024 to US$0.75 in the latest quarter, giving investors a new perspective on earnings power as...

Valuation snapshot and recent share performance Cognizant Technology Solutions (CTSH) has drawn fresh attention as investors reassess large IT services firms, with the stock recently closing at $76.84 and showing mixed returns over the past year. Over the past month, the share price shows a 9.19% decline, while the past 3 months reflect a 4.97% gain. The stock is also down 5.46% year to date and 10.34% over the past year. This performance is set against a 5.07% annual revenue growth rate and...

Okta expanded its partnership with the PGA of America to secure AI-driven digital experiences across the PGA ecosystem. The collaboration focuses on identity management for fans, players, and partners interacting with PGA digital platforms. The news comes with Okta shares at $82.15 under ticker NasdaqGS:OKTA. For investors watching NasdaqGS:OKTA, this partnership highlights Okta’s role in securing large, high-profile digital environments. The stock trades at $82.15, with a 3 year return of...

Why UFP Industries’ recent trends are back in focus UFP Industries (UFPI) is back under the microscope after ongoing declines in unit sales, earnings per share, and returns on capital over the past two years raised fresh questions about the durability of its profit drivers. See our latest analysis for UFP Industries. At a share price of $112.72, UFP Industries has seen strong recent momentum, with a 30 day share price return of 18.82% and a 90 day share price return of 22.52%. This comes even...

Alpha Cash agreement puts ACI Worldwide in focus ACI Worldwide (ACIW) has become the payments infrastructure provider for Alpha Modus’s Alpha Cash platform, supporting electronic and paper-based bill payments across convenience, grocery, and community retail locations nationwide. This multi-year services agreement targets consumers who rely on cash, alternative financial services, or hybrid digital and physical experiences, and it highlights ACI’s role in regulated remittance and bill payment...

In recent weeks, Applied Optoelectronics reported its first volume order for 800G data‑center transceivers from a major hyperscale customer and signaled strong demand ahead of its late‑February 2026 earnings update. The company’s high‑speed laser transceivers, seen as key to meeting AI‑driven bandwidth needs, are becoming a central focus for investors assessing its role in next‑generation data infrastructure. We’ll now examine how this early volume traction in 800G data‑center optics shapes...

Vicor (NasdaqGS:VICR) reports a surge in high margin IP licensing and royalty revenue following favorable International Trade Commission (ITC) rulings. The ITC outcomes support Vicor's efforts to monetize its power conversion intellectual property across a broader set of industry partners. These developments point to a potential inflection in Vicor's business model, with licensing now playing a larger role alongside product sales. For you as an investor, the key point is that Vicor is known...

Recent performance snapshot Ducommun (DCO) has drawn fresh attention after recent share price moves, with the stock last closing at $119.25. That puts the company’s recent 1 year and multi year total returns firmly in focus for investors. See our latest analysis for Ducommun. Those recent gains fit into a stronger trend, with a 30 day share price return of 18.02% and a 1 year total shareholder return of 78.71% pointing to building momentum rather than a short lived bounce. If Ducommun’s move...

Madrigal Pharmaceuticals granted equity inducement awards to 21 new non executive employees under its 2025 Inducement Plan. The equity grants are intended as hiring inducements and are separate from the company’s existing equity incentive programs. Madrigal Pharmaceuticals, NasdaqGS:MDGL, is adding to its workforce while its shares trade around $463.42. The stock has seen a 40.3% return over the past year and a 283.6% return over the past five years, despite a 22.0% decline year to date and...

If you are wondering whether East West Bancorp is offering fair value at its current share price, this breakdown will help you connect the recent share performance with what the fundamentals suggest. The stock last closed at US$118.46, with returns of 3.5% over the past 7 days, 0.7% over 30 days, 3.0% year to date, 19.1% over 1 year, 65.5% over 3 years, and 103.0% over 5 years. This naturally raises questions about what is already reflected in the price. Recent news coverage around US...

Why Archer-Daniels-Midland (ADM) Is Back On Investors’ Radar Archer-Daniels-Midland (ADM) is drawing fresh attention after a period of mixed short term performance, but with stronger recent momentum prompting investors to reassess the agricultural processor’s role in a diversified equity portfolio. See our latest analysis for Archer-Daniels-Midland. At a share price of US$65.43, ADM has given investors a 14.83% 90 day share price return and a 49.25% total shareholder return over the past...

Circle Internet Group (CRCL) is back in focus after agreeing to supply native USDC settlement infrastructure to prediction market Polymarket, while Ark Invest and Wall Street analysts increase attention during a period of sharp crypto volatility. See our latest analysis for Circle Internet Group. The Polymarket agreement and fresh partnerships on Circle Payments Network have arrived during a sharp reset in sentiment, with a 7 day share price return of 25.64% and a 90 day share price return of...

Hubbell Incorporated recently reported fourth-quarter 2025 results showing higher sales of US$1,492.7 million and net income of US$224.2 million versus a year earlier, and issued 2026 guidance calling for 7% to 9% total sales growth and GAAP diluted EPS of US$17.30 to US$18.00. Alongside these results, the company highlighted expanding margins, ongoing acquisitions such as DMC Power, and the launch of its Aclara360 grid analytics platform, underlining a growing emphasis on higher-value...

Dexcom has introduced new AI-powered upgrades to its Stelo platform, adding expanded Smart Food Logging and a broader nutrition database. The update also includes a redesigned Daily Insights feature that provides more personalized health recommendations for users managing metabolic health. DexCom (NasdaqGS:DXCM) is rolling out these Stelo updates as the stock trades at around $69.89, with a 5.0% return year to date and a 20.9% decline over the past year. The longer term picture has been...

What recent returns suggest about Nasdaq’s current setup Nasdaq (NDAQ) has seen a 3.4% decline over the past day and an 11.7% drop over the past week, extending to a 14.8% slide over the past month and a smaller 2% pullback over the past 3 months. See our latest analysis for Nasdaq. With the share price at $85.51 and a year to date share price return decline of 11.5% alongside a 14.8% 30 day share price return decline, momentum has recently cooled. This contrasts with the 1 year, 3 year and 5...

Insulet has launched its Omnipod 5 Automated Insulin Delivery System in selected Middle Eastern markets. The company also introduced Omnipod Discover, a new data and analytics platform for diabetes management. Both products expand Insulet's global footprint and broaden its connected product ecosystem around Omnipod. Insulet, traded as NasdaqGS:PODD, is adding fresh product news at a time when its share price is $243.15. The stock has seen a 17.4% decline over the past 30 days and a 15.5%...

McDonald’s Board of Directors recently declared a quarterly cash dividend of US$1.86 per share, payable on March 17, 2026, to shareholders of record as of March 3, 2026, while rolling out attention-grabbing promotions such as McNugget Caviar kits and nostalgia-driven Happy Meal toys. These announcements, combined with leadership changes that move experienced international operators into key U.S. and finance roles, highlight how McDonald’s is pairing shareholder returns with brand campaigns...

If you are wondering whether Summit Therapeutics at around US$13.85 is pricing in too much hope or not enough, you are in the right place for a clear look at what the market might be implying about its value. The share price has seen sharp swings, with a 10.1% decline over the past week, a 25.8% decline over the past month, a 20.9% decline year to date, yet a very large gain over three years and an 87.9% gain over five years. These moves have come as Summit Therapeutics continues to attract...

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) received FDA approval for REDEMPLO for familial chylomicronemia syndrome and launched its first commercial product. The company announced a global partnership with Novartis to co develop a preclinical RNAi therapy targeting synucleinopathies. Arrowhead dosed the first subjects in a Phase 1/2a trial of ARO DIMER PA, a first in class dual target RNAi therapeutic for cardiovascular disease. Arrowhead focuses on RNA interference therapies, so this...

Investors wondering whether Nextpower is still fairly priced after a strong run, or if the share price has moved ahead of the underlying value, will find that this article focuses squarely on what the current valuation might be indicating. The stock recently closed at US$114.44, with a 30 day return of 25.1% and a 1 year return of 140.4%. Over the last 7 days, however, the share price has pulled back 5.5%, which may reflect some reassessment of risk or profit taking after a 23.3% year to...